Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionDisposable, low-volume patch pump delivering continuous subcutaneous doses of liquid apomorphine base
Molecular Target Dopamine D2 receptor ; Dopamine D3 receptor (DRD3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today